Sean Kim
Stock Analyst at JonesTrading
(0.46)
# 3,971
Out of 4,880 analysts
8
Total ratings
33.33%
Success rate
-14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $0.62 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $14.02 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $0.80 | +650.00% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $0.33 | +1,718.73% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $9.41 | +176.30% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $5.47 | +27.97% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $14.02
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.80
Upside: +650.00%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $0.33
Upside: +1,718.73%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $9.41
Upside: +176.30%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $5.47
Upside: +27.97%